The mitigation of depression-like behaviors in Orai1 cKO mice following LPS challenge is consistent with growing evidence indicating that anti-inflammatory therapeutic agents mitigate major depression in some patients10, and suggests that targeting astrocyte-mediated inflammation may aid the quest for developing new treatments for inflammatory diseases of the brain. The gene discussed is ORAI1; the disease is depressive symptom measurement.